消化性溃疡的中医证治规律研究及临床疗效的系统评价
|
摘要
目的:通过消化性溃疡临床资料的回顾性分析以总结消化性溃疡中医证候分布特点及处方用药规律,为临床和科研工作提供参考,更好的发挥中医药治疗优势;总结导师周学文教授治疗消化性溃疡的处方用药等规律,推广导师临床经验及学术思想,丰富本病的中医治疗方法;对口服中药治疗消化性溃疡的随机对照试验(RCT)进行方法学质量和临床疗效及安全性评价,客观的评价中药在消化性溃疡治疗上的优势与不足,为中医药治疗消化性溃疡提供循证医学证据。
材料与方法:
1.通过中国生物医学文献数据库(CBM),以“消化性溃疡”为检索词进行主题检索,选择加权、全部树、全部副主题进行扩展检索,获得文献题录,再通过中国期刊全文数据库(CNKI)、维普全文数据库(VIP)、万方等中文数据库获得文献原文。对符合要求的文献将文献类别、证型名称、病例数、所用药物等进行录入,进行计量学分析。
2.将导师周学文教授治疗的115例活动期消化性溃疡患者的临床资料,进行数据录入,采用频数分析和关联规则分析的方法,初步总结本病的证候特征以及导师治疗本病的思维特点、处方用药规律等知识。
3.通过收集符合标准的中药治疗消化性溃疡的临床随机对照试验,按照Cochrane系统评价员手册5.0.2版及GRADE标准对试验方法学、证据质量进行评价,对提取的相关数据进行荟萃分析(meta分析)。
结果:
1.消化性溃疡的中医证治规律研究
共纳入1103篇原文。其中辩证论治类文献168篇,非辨证论治类文献935篇。总体用药以甘草、白芍、白芨、乌贼骨、黄芪、元胡、白术、黄连、党参、蒲公英、三七、陈皮、丹参、茯苓、柴胡、香附、半夏、枳壳、砂仁、桂枝、木香等为多见。证型名称繁杂,在168篇辨证论治文献涉及中医证型名称达128种,通过归类汇总后有脾胃虚弱证、胃热炽盛证、瘀血停滞证、肝胃气滞证、胃阴亏虚证、饮食停滞证、寒邪客胃证、湿热中阻证、痰湿阻滞证、肝脾不和证、寒热错杂证、气虚血瘀证、其他(脾虚胃热、虚寒血瘀、热瘀胃络、虚实夹杂、岀血证）等证型，经统计分析?ば陀衅⑽感槿踔(32.04%)、肝胃气滞证(24.67%)、瘀血停滞证(12.14%)、胃阴亏虚证(8.46%)、胃热炽盛证(8.18%)、湿热中阻证(5.85%)六种。处方用药脾胃虚弱证常用药物有甘草、黄芪、白术、白芍、党参、桂枝、干姜等,即以六君子汤、黄芪建中汤、理中汤等为常用方剂,可适当加用白芨、元胡、乌贼骨、瓦楞子等生肌制酸,加砂仁、香附、木香等理气,丹参、三七等活血,黄连、蒲公英等清热;肝胃气滞证常用药物有甘草、柴胡、白芍、香附、枳壳、陈皮、乌贼骨、元胡等,即以柴胡疏肝散、金铃子散等为常用方剂,配合丹参、三七活血,黄连、蒲公英、黄芩等清热,黄芪、白术、党参等健脾,白芨、乌贼骨、瓦楞子等生肌制酸;瘀血停滞证常用药物有甘草、五灵脂、元胡、丹参、白芨、蒲黄、川楝子等,即以失笑散、丹参饮、金铃子散等为常用方剂,配合三七、赤芍、桃仁、川芎、红花等活血化瘀,香附、乌药、陈皮等理气,黄芪、党参、白术、当归等益气养血,黄连、蒲公英等清热解毒;胃阴亏虚证常用药物有麦冬、甘草、沙参、白芍、石斛、白芨、黄芪、生地、玉竹等,即以益胃汤、麦门冬汤、芍药甘草汤等为常用方剂,配伍乌贼骨、瓦楞子制酸,黄芪、白术、党参、当归等补气养血;胃热炽盛证常用药物以黄连、蒲公英、栀子、丹皮、黄芩清热解毒,元胡、丹参、三七等活血,白芨、乌贼骨、瓦楞子生肌制酸。香附、枳壳、青皮等理气,黄芪、白术健脾;湿热中阻证常用药物以黄连、半夏、茯苓、黄芩、苍术、蒲公英、厚朴、栀子、薏苡仁等清热利湿,白芨、乌贼骨、瓦楞子等生肌制酸,党参、白术、黄芪等健脾。
2.周学文教授治疗消化性溃疡的经验与数据挖掘
纳入115例消化性溃疡患者,临床症状以胃脘疼痛、痞满、反酸、口干、嗳气、烧心、纳呆、恶心、口苦、呕吐为主,其他症状还有寐差、大便干、腹痛、黑便、打嗝、烦躁易怒、大便溏、口粘等。舌质以舌红、红绛为多见,舌苔以黄腻苔、积粉苔、腐苔、薄黄苔多见,脉象以弦脉、弦滑脉及弦数脉为多见,胃镜下溃疡周围粘膜可见充血水肿。证型分布胃脘毒热证最为多(62%),其次为肝胃气滞证(15%)、脾胃虚弱证(11%),再次为瘀血停滞证、胃阴不足证,而脾胃虚寒最为少见(1%)。治疗上以清热解毒,敛疮生肌,配合补脾益气、疏肝、理气(行气)、活血等。治疗处方147首,用药91味,常用药物有黄芪、黄连、白芨、浙贝母、甘草、柴胡、苦参、蒲公英、乌贼骨、元胡、三七、青皮、苏叶、金铃子、煅瓦楞、白豆蔻、丹参、砂仁等。常用配伍有黄连和黄芪、金铃子和元胡、浙贝母和乌贼骨等等。
3.中药治疗消化性溃疡疗效及安全性的系统评价
纳入13篇随机对照试验(RCT),包括3036例患者,样本含量从72到494不等,所有研究方法学质量:①有3个研究描述了隐蔽分组情况,②有2个研究提及研究过程中存在病例的剔除、失访及退出,③所有研究均未进行意向性分析,④4个研究描述了不良反应的发生,⑤8个研究所用试验药物为研究者经验方或其院内制剂,⑥所有研究未进行临床试验注册;证据质量分析:按GRADE标准所有研究评价结果均为低质量或极低质量证据。Meta分析结果显示:所选RCT中部分中药治疗消化性溃疡的胃镜治愈率、中医症候疗效的有效率优于雷尼替丁(P=0.002,P=0.0004)。半年及一年溃疡的复发率低于雷尼替丁(P=0.004,P<0.0001);所选RCT中部分中药治疗消化性溃疡的胃镜有效率、中医症候疗效的治愈率与雷尼替丁没有明显差异(P=0.56,P=0.08);所选RCT中部分中药对HP阳性的消化性溃疡患者HP阴转率与雷尼替丁没有明显差异(P=0.10),与雷尼替丁+阿莫西林+甲硝唑无差异[RR=1.60(95%CI:0.94,2.73],与奥美拉唑+阿莫西林+替硝唑有差异RR=0.08(95%CI:0.03,0.23]。
结论:
1.消化性溃疡的中医证治规律研究
消化性溃疡的常见证型有脾胃虚弱证、肝胃气滞证、瘀血停滞证、胃阴亏虚证、胃热炽盛证、湿热中阻证等。脾胃虚弱是消化性溃疡发病的主要机制,也是溃疡复发的主要原因。治疗上脾胃虚弱证以六君子汤、黄芪建中汤、理中汤等为常用方剂,可适当加用生肌制酸药,配伍理气活血、清热解毒之品;肝胃气滞证以柴胡疏肝散、金铃子散等为常用方剂,配合活血清热解毒,及健脾、生肌制酸之品;瘀血停滞证以失笑散、丹参饮、金铃子散等为常用方剂,配伍三七、赤芍、桃仁、川芎、红花等活血化瘀,配伍理气健脾益气养血、清热解毒之品;胃阴亏虚证以益胃汤、麦门冬汤、芍药甘草汤等为常用方剂,配伍制酸、健脾补气养血之品;胃热炽盛证以黄连、蒲公英、栀子、丹皮、黄芩清热解毒,配伍理气活血及生肌制酸、健脾之品;湿热中阻证常用药物以黄连、半夏、茯苓、黄芩、苍术、蒲公英厚朴、栀子、薏苡仁等清热利湿,配伍生肌制酸、健脾益气之品。无论哪一证型的治疗用药都或多或少的有黄芪、白术等健脾益气类药物及白芨、乌贼骨、瓦楞子等生肌制酸药物以提高疗效。
2.周学文教授治疗消化性溃疡的经验与数据挖掘
导师周学文教授针对消化性溃疡的临床特征及胃镜改变提出“胃痈”病名,创新“毒热”学说,认为其病机以脾胃虚弱为本,毒热蕴结为标,久病入络,气血瘀滞为变。提出“以痈论治”的治疗思想,将“消”、“托”、“补”三法引入治疗,以清热解毒、消痈生肌为主要治法,确立主体方药消痈溃得康,临证随机调节,注重药物的配伍应用,强调尤要处理好肝脾、胆胃关系,注意调节气机升降,适当使用活血化瘀、滋养胃阴及调脾养心之品,同时可以针对幽门螺杆菌(hp)用药及提高疗效。强调观看舌象以明疾病的进退预后,药物剂量不宜过大,重视煎服法及饮食调摄等。
3.中药治疗消化性溃疡疗效及安全性的系统评价
部分中药治疗消化性溃疡的胃镜治愈率、中医症候疗效的有效率优于雷尼替丁,半年及一年溃疡的复发率低于雷尼替丁,部分中药治疗消化性溃疡的胃镜有效率、中医症候疗效的治愈率与雷尼替丁没有明显差异,部分中药对HP阳性的消化性溃疡患者HP阴转率与雷尼替丁没有明显差异,与三联疗法(雷尼替丁+阿莫西林+甲硝唑)无差异,而与(奥美拉唑+阿莫西林+替硝唑)有差异。但由于所有研究的方法学质量与证据质量较低,对本研究的结果需谨慎对待,今后应更加规范科研设计,延长随访时间,注重药物安全性与不良反应,并按照中医药随机对照试验报告统一规范(CONSORT for TCM)中推荐的流程和项目报告RCT。
Purpose:In order to provide reference to clinical experience and scientific research, and reflect advantages of Traditional Chinese Medicine (TCM) in peptic ulcer (PU), this article conclude the differentiation-prescription rules of PU by a retrospective analysis of clinical data of PU;In order to spread clinical experience and academic thoughts of professor Zhou Xuewen,through summarized the rules of prescriptions to treat PU;analyzed the methodology for quality , curative effect and clinical security about literature of oral traditional chinese medicine randomized controlled trials (RCT) in PU,and valuate objectively the advantages and disadvantages of TCM in the treatment of peptic ulcer, so as to provide evidence of evidence-based medicine(EBM)
Material and method:
1.To get the catalog of the documents through China biomedical(CBM) literature database by using peptic ulcer (PU)as key words for subject access select weighted, all trees, all sub-themes to extend search. Then access to bibliography by the Chinese Academic Journal (CNKI) ,VIP Full-text databases,( VIP), WANFANG Database to obtain the original documents in Chinese,Have a metrological analysis with the literature that meet the requirements of document class name of syndrome the number of cases drugs used
2. Entering the clinical data of the 115 example of the active stage peptic ulcer patients. Concluded the character of the disease symptom and the knowledge of the treatment and laws of using drugs by using the methods of frequency analysis and the associated rules method of analysis.
3.Through collecting standard chinese medicine treatment of peptic ulcer R randomized controlled trials. In accordance with the Handbook 5.0.2 System Evaluation GRADE standards .The methodology of the literature Quality of Literature Evaluation .The extracted meta-analysis of relevant data.
Results:
1. The research of PU through TCM treatment
Incorporate 1103 pieces of original artial, there were 168 pieces artia were about treatment according to syndrome differentiation and 935 were not, The drugs are more common in Licorice, white peony root, Baiji, cuttlefish bone, astragalus, Yuan Hu, Bai Zhu, berberine, Codonopsis, Dandelion, Panax, dried tangerine peel, red sage root, Poria, Bupleurum, Cyperus rotundus, Pinellia, Citrus aurantium, Amomum, Guizhi , Mu-xaing, etc . The names of the syndrome were miscellaneous, there were 128 types of name among in 168 pieces text that were about treatment according to syndrome differentiation. Through the classified summary there were spleen-stomach deficiency, certificates stomach heat flaming, blood stasis stagnation card, liver and stomach-Qi stagnation, stomach-yin deficiency, diet stagnation card, Han-xie off stomach card, hot and humid in the resistance card, phlegm block card, disharmony between liver and spleeen, cold and heat mixed card, with Qi-deficiency and blood -stasis , the others (spleen-stomach heat, cold and blood stasis, heat stasis stomac-luo, the actual situation inclusions, Bleeding), and other syndromes, and there were six types of syndrome were in common: spleen-stomach deficiency (32.04%), liver and stomach qi stagnation (24.67%), blood stasis stagnation card (12.14%), stomach-yin deficiency syndrome (8.46%), stomach heat flaming card (8.18%), hot and humid in the retention syndrome (5.85%).
The prescription to treat the syndrome of spleen-stomach deficiency is Licorice, Astragalus, Atractylodes, white peony root, Codonopsis, cassia twig, dry ginger, etc., which is so called Liujunzi Tang, Huangqi-Jianzhong Tang, Li Zhong Tang and can be properly added with Baiji, Yuan Hu, cuttlefish bone, and other myogenic corrugated sub-acid, add villosum, Cyperus rotundus,mu-xiang and other regulating-qi drugs, Salvia, and notoginseng, berberine, dandelion and other heat; The prescription to treat the syndrome of liver and stomach qi stagnation is Licorice, Bupleurum, white peony root, Cyperus rotundus, Citrus aurantium, Citrus, cuttlefish bone, Yuan Hu, etc., which is so called ChaiHuShuGanSan, Jin Ling Zi Powder as the popular prescription, with panax blood Salvia, Scutellaria, etc. Coptis dandelion Heat, Astragalus, Atractylodes, Codonopsis other spleen, Baiji, cuttlefish bone, corrugated sub-acid and other myogenic; The prescription to treat the syndrome of blood stasis stagnation card is Licorice, Wulingzhi, Yuan Hu, SM, Baiji, Puhuang, Toosendan so, that Shixiaosan, Salvia drink, Jin Ling Zi Powder as the commonly used prescriptions. With notoginseng, red peony root, peach kernel, Chuanxiong, safflower and other blood circulation, Cyperus rotundus, aggregata, dried tangerine peel, etc. qi, Astragalus, Codonopsis, Atractylodes, Angelica and other nourishing Qi, berberine, and dandelion to clearing away heat and toxic material; The prescription to treat the syndrome of stomach yin deficiency is Radix, licorice root, Radix, white peony root, Dendrobium, Baiji, astragalus, habitat, Polygonatum and so on. That is, Yiwei Tang, wheat Asp soup, such as the commonly used SGD prescription, compatibility cuttlefish bone, corrugated sub-acid, Astragalus, Atractylodes, Codonopsis, angelica and other nourishing qi; The prescription to treat the syndrome of stomach heat flaming card is Berberine, dandelion, gardenia, peony tree bark, skullcap Qingrejiedu, Yuan Hu, Salvia, and notoginseng blood, Baiji, cuttlefish bone, corrugated sub-myogenic acid. Cyperus rotundus, Citrus aurantium, blue, etc. qi, Astragalus, Atractylodes spleen; The prescription to treat the syndrome of hot and humid in the retention is Coptis, Pinellia, Poria, skullcap, herb, dandelion Magnolia, gardenia, Coix seed and other heat dampness, Baiji cuttlefish bone, corrugated sub-acid and other myogenic, Codonopsis, Atractylodes, Astragalus spleen
2. Professor Zhou Xuewen experience in treatment of peptic ulcer and Data Mining
The main clinical syndromes of the 115 PU patients are Epigastric pain, fullness, acid regurgitation, dry mouth, belching, heartburn, poor appetite, nausea, mouth pain, vomiting and the other syndromes are poor sleep, dry stool, abdominal pain, black stools, hiccups, irritability, loose stools, mouth stick, etc. Tongue to tongue is red, red purple is more common, tongue with yellow greasy fur product powder coating, corrosion coating, thin yellow fur common, pulse to pulse string, string taut slippery pulse and the pulse is more common, Endoscopic mucosal visible edema around the ulcer; the distribution stomach syndrome Abdominal most toxic heat syndrome and more (62%), followed by the syndrome of liver and stomach qi stagnation (15%), spleen and stomach deficiency card (11%), again blood stasis stagnation card, certificate of stomach yin deficiency, and the most rare spleen and stomach deficiency with cold (1%). Detoxification treatment to heat-based, with invigoratings Spleen Qi, myogenic convergence sores, su-gan, regulate qi (qi), blood circulation and so on. 147 treatment regimen, medication 91 flavor, commonly used drugs are Astragalus, Coptis, Baiji, Zhejiang Fritillaria, licorice root, Bupleurum, Sophora, dandelion, cuttlefish bone, Yuan Hu, Panax, blue, sage, golden bell son Duan corrugated, white cardamom, Salvia, Amomum. Compatibility with Coptis and Astragalus Common, Son, and Jin Ling Yuan Hu, and cuttlefish bone Fritillaria.
3. The system evaluation of the treatment to PU by using TCM
Included 13 randomized controlled trials (RCT), including 3036 cases of patients, sample size ranged from 72 to 494,the quality of all research methodological:①There are 3 case studies described concealment;②There are two studies have addressed the existence of cases during the study excluded lost, and exit,③all studies were not intentional analysis,④4 studies described the incidence of adverse reactions,⑤8 research institutes researchers with experience in testing drugs for the hospital or its agents,⑥study did not conduct clinical trials of all registered. The Quality of evidence: Evaluation of all research results are evidence of low quality or low quality. Meta analysis showed: endoscopic treatment of peptic ulcer cure and efficacy of traditional Chinese medicine effective symptom by some traditional Chinese medicine is better than ranitidine(P=0.002,P=0.0004), six months and one year recurrence rate of ulcers than ranitidine(P=0.004,P<0.0001);endoscopic treatment of peptic ulcer efficacy and cure of traditional Chinese medicine effective symptom by some traditional Chinese medicine as to as ranitidine(P=0.56,P=0.08);and HP conversion rate of HP-positive peptic ulcer patients did not differ significantly ranitidine(P=0.10),and not differ significantly ranitidine+ Amoxicillin + metronidazole [RR=1.60(95%CI:0.94,2.73],and differ significantly Omeprazole+Amoxicillin + tinidazole,RR=0.08(95%CI:0.03,0.23].
Conclusion:
1. The research of PU through TCM treatment
The common syndrome of PU are: spleen and stomach deficiency, liver and stomach Qi stagnation, blood stasis stagnation card, stomach yin deficiency syndrome, stomach heat flaming card, hot and humid in the resistance card. spleen and stomach deficiency is the main mechanism for peptic ulcer, and for ulcer recurrence. Treatment of spleen and stomach deficiency card to Liujunzi Tang, Astragalus Decoction, the rationale for the commonly used prescriptions in the Tang may be appropriate to increase myogenic acid drug use, compatibility qi and blood circulation, detoxification of the goods; liver and stomach Qi stagnation to Bupleurum Liver Powder, Jin Ling Zi Powder as the commonly used formulas, with the blood detoxification, and spleen, tissue regeneration acid of the goods; stasis stagnation card to Shixiaosan, Salvia drink, Jin Ling Zi Powder as the common prescription, compatibility Notoginseng, red peony root, peach kernel, Chuanxiong, safflower and other blood circulation, spleen qi Qi and blood compatibility, detoxification of chemicals; stomach yin deficiency syndrome in Yiwei Tang, wheat Asp soup, peony and licorice soup For commonly used prescription, compatibility acid, spleen qi nourishing of the goods; stomach heat flaming card to berberine, dandelion, gardenia, peony tree bark, skullcap Qingrejiedu, compatibility qi and blood circulation and tissue regeneration acid, the spleen of the goods; Heat retention syndrome commonly used in drugs to berberine, Pinellia, Poria, skullcap, herb, dandelion, magnolia, gardenia, Coix seed and other heat and dampness, compatibility myogenic acid, spleen Qi of the product. No matter what type of treatment cards are more or less medication Astragalus, Atractylodes drugs such as spleen Qi and Baiji, cuttlefish bone, corrugated sub-acid drugs such as tissue regeneration to improve the efficacy.
2. Professor Zhou Xuewen experience in treatment of peptic ulcer and Data Mining
Professor Zhou Xuewen instructors for the clinical characteristics of peptic ulcer and endoscopic changes to the "stomach carbuncle" disease name, and innovation "toxic heat”theory that the pathogenesis of the spleen and stomach-oriented, heat Accumulation as the standard drug, chronic illness into the network, Blood stasis to change. That "the carbuncle on the administration " thought the treatment would "eliminate","care","up " three methods to introduce treatment to detoxify, eliminate the main governing myogenic carbuncle law, establishing the main prescription consumer health carbuncle may collapse, Clinical randomized conditioning, pay attention to the compatibility of drug application, emphasizing in particular handle well the liver and spleen, stomach, gall bladder relationship, pay attention to adjust the air-lift, the appropriate use of blood circulation, nourish Stomach-Yin and Yang Xin of the goods transferred spleen, and can for Helicobacter pylori Pylori (hp) and improved treatment efficacy. Stressed out watching the tongue to advance and retreat of disease prognosis, drug dosage should not be too large, attention to diet ,extracting and taking drugs method.
3. The system evaluation of the treatment to PU by using TCM endoscopic treatment of peptic ulcer cure and efficacy of traditional
Chinese medicine effective symptom by some traditional Chinese medicine is better than ranitidine, six months and one year recurrence rate of ulcers lower than ranitidine;endoscopic treatment of peptic ulcer efficacy and cure of traditional Chinese medicine effective symptom by some traditional Chinese medicine as to as ranitidine;and HP conversion rate of HP-positive peptic ulcer patients did not differ significantly ranitidine, not differ significantly ranitidine+ Amoxicillin + metronidazole ,and differ significantly Omeprazole+Amoxicillin + tinidazole.Because all of the methodological quality and evidence of low quality, the results of this study should be cautious in the future and should be more Specifications research design, extended follow-up time, pay attention to drug safety and adverse reactions, and in accordance with the medical report of randomized controlled trials of standardized (CONSORT for TCM) in the recommended process and project reporting RCT.
材料与方法:
1.通过中国生物医学文献数据库(CBM),以“消化性溃疡”为检索词进行主题检索,选择加权、全部树、全部副主题进行扩展检索,获得文献题录,再通过中国期刊全文数据库(CNKI)、维普全文数据库(VIP)、万方等中文数据库获得文献原文。对符合要求的文献将文献类别、证型名称、病例数、所用药物等进行录入,进行计量学分析。
2.将导师周学文教授治疗的115例活动期消化性溃疡患者的临床资料,进行数据录入,采用频数分析和关联规则分析的方法,初步总结本病的证候特征以及导师治疗本病的思维特点、处方用药规律等知识。
3.通过收集符合标准的中药治疗消化性溃疡的临床随机对照试验,按照Cochrane系统评价员手册5.0.2版及GRADE标准对试验方法学、证据质量进行评价,对提取的相关数据进行荟萃分析(meta分析)。
结果:
1.消化性溃疡的中医证治规律研究
共纳入1103篇原文。其中辩证论治类文献168篇,非辨证论治类文献935篇。总体用药以甘草、白芍、白芨、乌贼骨、黄芪、元胡、白术、黄连、党参、蒲公英、三七、陈皮、丹参、茯苓、柴胡、香附、半夏、枳壳、砂仁、桂枝、木香等为多见。证型名称繁杂,在168篇辨证论治文献涉及中医证型名称达128种,通过归类汇总后有脾胃虚弱证、胃热炽盛证、瘀血停滞证、肝胃气滞证、胃阴亏虚证、饮食停滞证、寒邪客胃证、湿热中阻证、痰湿阻滞证、肝脾不和证、寒热错杂证、气虚血瘀证、其他(脾虚胃热、虚寒血瘀、热瘀胃络、虚实夹杂、岀血证）等证型，经统计分析?ば陀衅⑽感槿踔(32.04%)、肝胃气滞证(24.67%)、瘀血停滞证(12.14%)、胃阴亏虚证(8.46%)、胃热炽盛证(8.18%)、湿热中阻证(5.85%)六种。处方用药脾胃虚弱证常用药物有甘草、黄芪、白术、白芍、党参、桂枝、干姜等,即以六君子汤、黄芪建中汤、理中汤等为常用方剂,可适当加用白芨、元胡、乌贼骨、瓦楞子等生肌制酸,加砂仁、香附、木香等理气,丹参、三七等活血,黄连、蒲公英等清热;肝胃气滞证常用药物有甘草、柴胡、白芍、香附、枳壳、陈皮、乌贼骨、元胡等,即以柴胡疏肝散、金铃子散等为常用方剂,配合丹参、三七活血,黄连、蒲公英、黄芩等清热,黄芪、白术、党参等健脾,白芨、乌贼骨、瓦楞子等生肌制酸;瘀血停滞证常用药物有甘草、五灵脂、元胡、丹参、白芨、蒲黄、川楝子等,即以失笑散、丹参饮、金铃子散等为常用方剂,配合三七、赤芍、桃仁、川芎、红花等活血化瘀,香附、乌药、陈皮等理气,黄芪、党参、白术、当归等益气养血,黄连、蒲公英等清热解毒;胃阴亏虚证常用药物有麦冬、甘草、沙参、白芍、石斛、白芨、黄芪、生地、玉竹等,即以益胃汤、麦门冬汤、芍药甘草汤等为常用方剂,配伍乌贼骨、瓦楞子制酸,黄芪、白术、党参、当归等补气养血;胃热炽盛证常用药物以黄连、蒲公英、栀子、丹皮、黄芩清热解毒,元胡、丹参、三七等活血,白芨、乌贼骨、瓦楞子生肌制酸。香附、枳壳、青皮等理气,黄芪、白术健脾;湿热中阻证常用药物以黄连、半夏、茯苓、黄芩、苍术、蒲公英、厚朴、栀子、薏苡仁等清热利湿,白芨、乌贼骨、瓦楞子等生肌制酸,党参、白术、黄芪等健脾。
2.周学文教授治疗消化性溃疡的经验与数据挖掘
纳入115例消化性溃疡患者,临床症状以胃脘疼痛、痞满、反酸、口干、嗳气、烧心、纳呆、恶心、口苦、呕吐为主,其他症状还有寐差、大便干、腹痛、黑便、打嗝、烦躁易怒、大便溏、口粘等。舌质以舌红、红绛为多见,舌苔以黄腻苔、积粉苔、腐苔、薄黄苔多见,脉象以弦脉、弦滑脉及弦数脉为多见,胃镜下溃疡周围粘膜可见充血水肿。证型分布胃脘毒热证最为多(62%),其次为肝胃气滞证(15%)、脾胃虚弱证(11%),再次为瘀血停滞证、胃阴不足证,而脾胃虚寒最为少见(1%)。治疗上以清热解毒,敛疮生肌,配合补脾益气、疏肝、理气(行气)、活血等。治疗处方147首,用药91味,常用药物有黄芪、黄连、白芨、浙贝母、甘草、柴胡、苦参、蒲公英、乌贼骨、元胡、三七、青皮、苏叶、金铃子、煅瓦楞、白豆蔻、丹参、砂仁等。常用配伍有黄连和黄芪、金铃子和元胡、浙贝母和乌贼骨等等。
3.中药治疗消化性溃疡疗效及安全性的系统评价
纳入13篇随机对照试验(RCT),包括3036例患者,样本含量从72到494不等,所有研究方法学质量:①有3个研究描述了隐蔽分组情况,②有2个研究提及研究过程中存在病例的剔除、失访及退出,③所有研究均未进行意向性分析,④4个研究描述了不良反应的发生,⑤8个研究所用试验药物为研究者经验方或其院内制剂,⑥所有研究未进行临床试验注册;证据质量分析:按GRADE标准所有研究评价结果均为低质量或极低质量证据。Meta分析结果显示:所选RCT中部分中药治疗消化性溃疡的胃镜治愈率、中医症候疗效的有效率优于雷尼替丁(P=0.002,P=0.0004)。半年及一年溃疡的复发率低于雷尼替丁(P=0.004,P<0.0001);所选RCT中部分中药治疗消化性溃疡的胃镜有效率、中医症候疗效的治愈率与雷尼替丁没有明显差异(P=0.56,P=0.08);所选RCT中部分中药对HP阳性的消化性溃疡患者HP阴转率与雷尼替丁没有明显差异(P=0.10),与雷尼替丁+阿莫西林+甲硝唑无差异[RR=1.60(95%CI:0.94,2.73],与奥美拉唑+阿莫西林+替硝唑有差异RR=0.08(95%CI:0.03,0.23]。
结论:
1.消化性溃疡的中医证治规律研究
消化性溃疡的常见证型有脾胃虚弱证、肝胃气滞证、瘀血停滞证、胃阴亏虚证、胃热炽盛证、湿热中阻证等。脾胃虚弱是消化性溃疡发病的主要机制,也是溃疡复发的主要原因。治疗上脾胃虚弱证以六君子汤、黄芪建中汤、理中汤等为常用方剂,可适当加用生肌制酸药,配伍理气活血、清热解毒之品;肝胃气滞证以柴胡疏肝散、金铃子散等为常用方剂,配合活血清热解毒,及健脾、生肌制酸之品;瘀血停滞证以失笑散、丹参饮、金铃子散等为常用方剂,配伍三七、赤芍、桃仁、川芎、红花等活血化瘀,配伍理气健脾益气养血、清热解毒之品;胃阴亏虚证以益胃汤、麦门冬汤、芍药甘草汤等为常用方剂,配伍制酸、健脾补气养血之品;胃热炽盛证以黄连、蒲公英、栀子、丹皮、黄芩清热解毒,配伍理气活血及生肌制酸、健脾之品;湿热中阻证常用药物以黄连、半夏、茯苓、黄芩、苍术、蒲公英厚朴、栀子、薏苡仁等清热利湿,配伍生肌制酸、健脾益气之品。无论哪一证型的治疗用药都或多或少的有黄芪、白术等健脾益气类药物及白芨、乌贼骨、瓦楞子等生肌制酸药物以提高疗效。
2.周学文教授治疗消化性溃疡的经验与数据挖掘
导师周学文教授针对消化性溃疡的临床特征及胃镜改变提出“胃痈”病名,创新“毒热”学说,认为其病机以脾胃虚弱为本,毒热蕴结为标,久病入络,气血瘀滞为变。提出“以痈论治”的治疗思想,将“消”、“托”、“补”三法引入治疗,以清热解毒、消痈生肌为主要治法,确立主体方药消痈溃得康,临证随机调节,注重药物的配伍应用,强调尤要处理好肝脾、胆胃关系,注意调节气机升降,适当使用活血化瘀、滋养胃阴及调脾养心之品,同时可以针对幽门螺杆菌(hp)用药及提高疗效。强调观看舌象以明疾病的进退预后,药物剂量不宜过大,重视煎服法及饮食调摄等。
3.中药治疗消化性溃疡疗效及安全性的系统评价
部分中药治疗消化性溃疡的胃镜治愈率、中医症候疗效的有效率优于雷尼替丁,半年及一年溃疡的复发率低于雷尼替丁,部分中药治疗消化性溃疡的胃镜有效率、中医症候疗效的治愈率与雷尼替丁没有明显差异,部分中药对HP阳性的消化性溃疡患者HP阴转率与雷尼替丁没有明显差异,与三联疗法(雷尼替丁+阿莫西林+甲硝唑)无差异,而与(奥美拉唑+阿莫西林+替硝唑)有差异。但由于所有研究的方法学质量与证据质量较低,对本研究的结果需谨慎对待,今后应更加规范科研设计,延长随访时间,注重药物安全性与不良反应,并按照中医药随机对照试验报告统一规范(CONSORT for TCM)中推荐的流程和项目报告RCT。
Purpose:In order to provide reference to clinical experience and scientific research, and reflect advantages of Traditional Chinese Medicine (TCM) in peptic ulcer (PU), this article conclude the differentiation-prescription rules of PU by a retrospective analysis of clinical data of PU;In order to spread clinical experience and academic thoughts of professor Zhou Xuewen,through summarized the rules of prescriptions to treat PU;analyzed the methodology for quality , curative effect and clinical security about literature of oral traditional chinese medicine randomized controlled trials (RCT) in PU,and valuate objectively the advantages and disadvantages of TCM in the treatment of peptic ulcer, so as to provide evidence of evidence-based medicine(EBM)
Material and method:
1.To get the catalog of the documents through China biomedical(CBM) literature database by using peptic ulcer (PU)as key words for subject access select weighted, all trees, all sub-themes to extend search. Then access to bibliography by the Chinese Academic Journal (CNKI) ,VIP Full-text databases,( VIP), WANFANG Database to obtain the original documents in Chinese,Have a metrological analysis with the literature that meet the requirements of document class name of syndrome the number of cases drugs used
2. Entering the clinical data of the 115 example of the active stage peptic ulcer patients. Concluded the character of the disease symptom and the knowledge of the treatment and laws of using drugs by using the methods of frequency analysis and the associated rules method of analysis.
3.Through collecting standard chinese medicine treatment of peptic ulcer R randomized controlled trials. In accordance with the Handbook 5.0.2 System Evaluation GRADE standards .The methodology of the literature Quality of Literature Evaluation .The extracted meta-analysis of relevant data.
Results:
1. The research of PU through TCM treatment
Incorporate 1103 pieces of original artial, there were 168 pieces artia were about treatment according to syndrome differentiation and 935 were not, The drugs are more common in Licorice, white peony root, Baiji, cuttlefish bone, astragalus, Yuan Hu, Bai Zhu, berberine, Codonopsis, Dandelion, Panax, dried tangerine peel, red sage root, Poria, Bupleurum, Cyperus rotundus, Pinellia, Citrus aurantium, Amomum, Guizhi , Mu-xaing, etc . The names of the syndrome were miscellaneous, there were 128 types of name among in 168 pieces text that were about treatment according to syndrome differentiation. Through the classified summary there were spleen-stomach deficiency, certificates stomach heat flaming, blood stasis stagnation card, liver and stomach-Qi stagnation, stomach-yin deficiency, diet stagnation card, Han-xie off stomach card, hot and humid in the resistance card, phlegm block card, disharmony between liver and spleeen, cold and heat mixed card, with Qi-deficiency and blood -stasis , the others (spleen-stomach heat, cold and blood stasis, heat stasis stomac-luo, the actual situation inclusions, Bleeding), and other syndromes, and there were six types of syndrome were in common: spleen-stomach deficiency (32.04%), liver and stomach qi stagnation (24.67%), blood stasis stagnation card (12.14%), stomach-yin deficiency syndrome (8.46%), stomach heat flaming card (8.18%), hot and humid in the retention syndrome (5.85%).
The prescription to treat the syndrome of spleen-stomach deficiency is Licorice, Astragalus, Atractylodes, white peony root, Codonopsis, cassia twig, dry ginger, etc., which is so called Liujunzi Tang, Huangqi-Jianzhong Tang, Li Zhong Tang and can be properly added with Baiji, Yuan Hu, cuttlefish bone, and other myogenic corrugated sub-acid, add villosum, Cyperus rotundus,mu-xiang and other regulating-qi drugs, Salvia, and notoginseng, berberine, dandelion and other heat; The prescription to treat the syndrome of liver and stomach qi stagnation is Licorice, Bupleurum, white peony root, Cyperus rotundus, Citrus aurantium, Citrus, cuttlefish bone, Yuan Hu, etc., which is so called ChaiHuShuGanSan, Jin Ling Zi Powder as the popular prescription, with panax blood Salvia, Scutellaria, etc. Coptis dandelion Heat, Astragalus, Atractylodes, Codonopsis other spleen, Baiji, cuttlefish bone, corrugated sub-acid and other myogenic; The prescription to treat the syndrome of blood stasis stagnation card is Licorice, Wulingzhi, Yuan Hu, SM, Baiji, Puhuang, Toosendan so, that Shixiaosan, Salvia drink, Jin Ling Zi Powder as the commonly used prescriptions. With notoginseng, red peony root, peach kernel, Chuanxiong, safflower and other blood circulation, Cyperus rotundus, aggregata, dried tangerine peel, etc. qi, Astragalus, Codonopsis, Atractylodes, Angelica and other nourishing Qi, berberine, and dandelion to clearing away heat and toxic material; The prescription to treat the syndrome of stomach yin deficiency is Radix, licorice root, Radix, white peony root, Dendrobium, Baiji, astragalus, habitat, Polygonatum and so on. That is, Yiwei Tang, wheat Asp soup, such as the commonly used SGD prescription, compatibility cuttlefish bone, corrugated sub-acid, Astragalus, Atractylodes, Codonopsis, angelica and other nourishing qi; The prescription to treat the syndrome of stomach heat flaming card is Berberine, dandelion, gardenia, peony tree bark, skullcap Qingrejiedu, Yuan Hu, Salvia, and notoginseng blood, Baiji, cuttlefish bone, corrugated sub-myogenic acid. Cyperus rotundus, Citrus aurantium, blue, etc. qi, Astragalus, Atractylodes spleen; The prescription to treat the syndrome of hot and humid in the retention is Coptis, Pinellia, Poria, skullcap, herb, dandelion Magnolia, gardenia, Coix seed and other heat dampness, Baiji cuttlefish bone, corrugated sub-acid and other myogenic, Codonopsis, Atractylodes, Astragalus spleen
2. Professor Zhou Xuewen experience in treatment of peptic ulcer and Data Mining
The main clinical syndromes of the 115 PU patients are Epigastric pain, fullness, acid regurgitation, dry mouth, belching, heartburn, poor appetite, nausea, mouth pain, vomiting and the other syndromes are poor sleep, dry stool, abdominal pain, black stools, hiccups, irritability, loose stools, mouth stick, etc. Tongue to tongue is red, red purple is more common, tongue with yellow greasy fur product powder coating, corrosion coating, thin yellow fur common, pulse to pulse string, string taut slippery pulse and the pulse is more common, Endoscopic mucosal visible edema around the ulcer; the distribution stomach syndrome Abdominal most toxic heat syndrome and more (62%), followed by the syndrome of liver and stomach qi stagnation (15%), spleen and stomach deficiency card (11%), again blood stasis stagnation card, certificate of stomach yin deficiency, and the most rare spleen and stomach deficiency with cold (1%). Detoxification treatment to heat-based, with invigoratings Spleen Qi, myogenic convergence sores, su-gan, regulate qi (qi), blood circulation and so on. 147 treatment regimen, medication 91 flavor, commonly used drugs are Astragalus, Coptis, Baiji, Zhejiang Fritillaria, licorice root, Bupleurum, Sophora, dandelion, cuttlefish bone, Yuan Hu, Panax, blue, sage, golden bell son Duan corrugated, white cardamom, Salvia, Amomum. Compatibility with Coptis and Astragalus Common, Son, and Jin Ling Yuan Hu, and cuttlefish bone Fritillaria.
3. The system evaluation of the treatment to PU by using TCM
Included 13 randomized controlled trials (RCT), including 3036 cases of patients, sample size ranged from 72 to 494,the quality of all research methodological:①There are 3 case studies described concealment;②There are two studies have addressed the existence of cases during the study excluded lost, and exit,③all studies were not intentional analysis,④4 studies described the incidence of adverse reactions,⑤8 research institutes researchers with experience in testing drugs for the hospital or its agents,⑥study did not conduct clinical trials of all registered. The Quality of evidence: Evaluation of all research results are evidence of low quality or low quality. Meta analysis showed: endoscopic treatment of peptic ulcer cure and efficacy of traditional Chinese medicine effective symptom by some traditional Chinese medicine is better than ranitidine(P=0.002,P=0.0004), six months and one year recurrence rate of ulcers than ranitidine(P=0.004,P<0.0001);endoscopic treatment of peptic ulcer efficacy and cure of traditional Chinese medicine effective symptom by some traditional Chinese medicine as to as ranitidine(P=0.56,P=0.08);and HP conversion rate of HP-positive peptic ulcer patients did not differ significantly ranitidine(P=0.10),and not differ significantly ranitidine+ Amoxicillin + metronidazole [RR=1.60(95%CI:0.94,2.73],and differ significantly Omeprazole+Amoxicillin + tinidazole,RR=0.08(95%CI:0.03,0.23].
Conclusion:
1. The research of PU through TCM treatment
The common syndrome of PU are: spleen and stomach deficiency, liver and stomach Qi stagnation, blood stasis stagnation card, stomach yin deficiency syndrome, stomach heat flaming card, hot and humid in the resistance card. spleen and stomach deficiency is the main mechanism for peptic ulcer, and for ulcer recurrence. Treatment of spleen and stomach deficiency card to Liujunzi Tang, Astragalus Decoction, the rationale for the commonly used prescriptions in the Tang may be appropriate to increase myogenic acid drug use, compatibility qi and blood circulation, detoxification of the goods; liver and stomach Qi stagnation to Bupleurum Liver Powder, Jin Ling Zi Powder as the commonly used formulas, with the blood detoxification, and spleen, tissue regeneration acid of the goods; stasis stagnation card to Shixiaosan, Salvia drink, Jin Ling Zi Powder as the common prescription, compatibility Notoginseng, red peony root, peach kernel, Chuanxiong, safflower and other blood circulation, spleen qi Qi and blood compatibility, detoxification of chemicals; stomach yin deficiency syndrome in Yiwei Tang, wheat Asp soup, peony and licorice soup For commonly used prescription, compatibility acid, spleen qi nourishing of the goods; stomach heat flaming card to berberine, dandelion, gardenia, peony tree bark, skullcap Qingrejiedu, compatibility qi and blood circulation and tissue regeneration acid, the spleen of the goods; Heat retention syndrome commonly used in drugs to berberine, Pinellia, Poria, skullcap, herb, dandelion, magnolia, gardenia, Coix seed and other heat and dampness, compatibility myogenic acid, spleen Qi of the product. No matter what type of treatment cards are more or less medication Astragalus, Atractylodes drugs such as spleen Qi and Baiji, cuttlefish bone, corrugated sub-acid drugs such as tissue regeneration to improve the efficacy.
2. Professor Zhou Xuewen experience in treatment of peptic ulcer and Data Mining
Professor Zhou Xuewen instructors for the clinical characteristics of peptic ulcer and endoscopic changes to the "stomach carbuncle" disease name, and innovation "toxic heat”theory that the pathogenesis of the spleen and stomach-oriented, heat Accumulation as the standard drug, chronic illness into the network, Blood stasis to change. That "the carbuncle on the administration " thought the treatment would "eliminate","care","up " three methods to introduce treatment to detoxify, eliminate the main governing myogenic carbuncle law, establishing the main prescription consumer health carbuncle may collapse, Clinical randomized conditioning, pay attention to the compatibility of drug application, emphasizing in particular handle well the liver and spleen, stomach, gall bladder relationship, pay attention to adjust the air-lift, the appropriate use of blood circulation, nourish Stomach-Yin and Yang Xin of the goods transferred spleen, and can for Helicobacter pylori Pylori (hp) and improved treatment efficacy. Stressed out watching the tongue to advance and retreat of disease prognosis, drug dosage should not be too large, attention to diet ,extracting and taking drugs method.
3. The system evaluation of the treatment to PU by using TCM endoscopic treatment of peptic ulcer cure and efficacy of traditional
Chinese medicine effective symptom by some traditional Chinese medicine is better than ranitidine, six months and one year recurrence rate of ulcers lower than ranitidine;endoscopic treatment of peptic ulcer efficacy and cure of traditional Chinese medicine effective symptom by some traditional Chinese medicine as to as ranitidine;and HP conversion rate of HP-positive peptic ulcer patients did not differ significantly ranitidine, not differ significantly ranitidine+ Amoxicillin + metronidazole ,and differ significantly Omeprazole+Amoxicillin + tinidazole.Because all of the methodological quality and evidence of low quality, the results of this study should be cautious in the future and should be more Specifications research design, extended follow-up time, pay attention to drug safety and adverse reactions, and in accordance with the medical report of randomized controlled trials of standardized (CONSORT for TCM) in the recommended process and project reporting RCT.
引文
[1]徐泽红.中药秦艽的研究进展.中国医药导报.2008,5(6):29-30.
[2]刘波,陆明,刘凡.野甘草乙醇提取物治疗大鼠胃溃疡作用的研究.现代中西医结合杂志.2007,16( 19):2654.
[3]唐绪刚,黄文权.五灵脂药理及临床应用概述.中国中医急症.2008,17(1):101-102.
[4]杨芳.沙棘的研究进展.第一军医大学分校学报.2004,27(1):79-81.
[5]陈少夫,贺丽,周卓等.党参对兔胃十二指肠粘膜中胃泌素、生长抑素的影响.中国医科大学学报.2002,31(3):164-165.
[6]Jackson CA. Rapid renal potassium adaptation in rats.Am J Physiol. 1992 Dec;263(6 Pt 2): 1098-104.
[7]龚静.大黄研究新进展.上海医药.2007,28(11):509-510.
[8]刘小英,温永顺,李裕福等.鱼腥草煎液对幽门螺杆菌的抑菌作用.第四军医大学学报.2006,27(8):676.
[9]Jiang XL, Cui HF. Different therapy for different types of ulcerative colitis in China.World J Gastroenterol. 2004 May 15;10(10):1513-20.
[10] Bae EA, Han MJ, Baek NI, Kim DH.In vitro anti-Helicobacter pylori activity of panaxytriol isolated from ginseng. Arch Pharm Res. 2001,24(4):297-9.
[11]钱士辉,王佾先,亢寿海等.陈皮提取物体内抗肿瘤作用的研究.中药材.2002, 26 (10) : 744-745.
[12]李庆耀,梁生林.陈皮的药用研究进展.中成药.2008,30(2):246-247.
[13]李廷荃,王希星,马贵同.黄芪对大鼠胃溃疡愈合过程中表皮生长因子及其受体表达的影响.山西中医.2007,23(2):61-63.
[14]孙仁山,陈晓红,程天民等.白芨对大鼠创面愈合几个要素的影响.中国临床康复.2003,7(29):3927-3929
[15]黄龑,孙清华,胡旭姣.白芨多糖对动物实验性胃溃疡的影响.现代中西医结合杂志.2009,18(6):612-613.
[16]丁志山,蒋福升,高承贤等.姜黄素对动物实验性胃溃疡的影响研究.中华中医药学刊,2008,26(10): 2225-2226.
[17]林海鸣,许琼明,孙晓飞.中草药.2008,39(12):1861-1863.
[18]卫自,沈业寿,史新强.天麻糖蛋白对小鼠实验性胃溃疡的保护作用.中药药理与临床.2007,23(6):34-35.
[19]梅武轩,曾常春.乳香提取物对大鼠乙酸胃溃疡愈合质量的影响.中国中西医结合消化杂志.2004,12(1):34-36.
[20] Tominaga K, Higuchi K, Iketani T et al .Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients. Inflammopharmacology. 2007,15(2):84-9.
[21]黄国栋,黄媛华,黄道富等.沙棘原花青素抗胃溃疡作用机制的研究.中成药.2008,30(5):632-635.
[22]付辛芳,刘晓红.丹参的药理作用与临床应用研究进展.中国药业.2006,15(1):76-77.
[23]李廷荃,马贵同,赵晋明.丹参对大鼠胃溃疡愈合过程中碱性成纤维细胞生长因子及其受体表达的影响.上海中医药杂志.2005,39(12):51-53.
[24]周奇.复方芪连煎剂治疗胃溃疡的实验研究.辽宁中医志.2005,32(12):1314-1315.
[25]张国民,刘慧萍,莫新民等.疏肝和胃丸对幽门结扎胃溃疡大鼠胃黏膜G细胞的调节作用.中华中医药学刊.2007,25(10):2102-2103。
[26]彭连生,胡锡元,曹淑亚等.健胃口服液抗消化性溃疡的药理研究.中国中西医结合消化杂志.2001,9(3):150-152.
[27]郝慧泉,田玉芝,曹径琳等.溃疡宁胶囊对大鼠幽门螺杆菌感染性胃溃疡实验研究.河北医药.2003,2(10):725-727.
[28]李春梅,梁代英,刘晋生等.养阴颗粒治疗幽门螺杆菌感染实验性胃溃疡的实验研究.北京中医杂志.2002,21(5):309-340.
[29]张俊杰,周庚生,顾伟忠,等.芩连合剂对幽门螺杆菌感染性胃溃疡大鼠氧自由基参数的影响.中国中医药科技.2O06,13(3):157-158
[30]李冀,毕塘辉,孙宇峰.四逆散抗实验性胃溃疡的药效学及作用机理研究.中华中医药学刊. 2007,25 (7):1317-1319.
[31]汪艳娟,王行宽,胡国恒.止血愈疡颗粒对幽门结扎型胃溃疡大鼠氧自由基参数的影响.中国中西医结合消化杂志.2002,10(4):206-208.
[32]白光,周学文.消痈溃得康对乙酸型胃溃疡大鼠血清NO NOS含量影响的实验研究.辽宁中医杂志.2010,37(1):2132-2133.
[33]张学智,李超波,梁文郁.复方田七胃痛胶囊对胃溃疡大鼠胃黏膜一氧化氮及内皮素的影响.中国中西医结合消化杂志.2008,16(5):281-283.
[34]李佃贵,王静,李瑞东.化浊降逆法对胃溃疡大鼠胃组织形态及血清NO血浆ET PAF含量的影响.河北职工医学院学报.2005,22(1):1-3.
[35]王滨,赵红晔,周丽等.溃疡平对胃溃疡大鼠胃黏膜组织中EGF和EGFRmRNA表达的影响.北京中医药大学学报.2008,31(11):759-762.
[36]谭永港,刘志承,张永锋等.健胃汤对大鼠胃溃疡愈合质量及表皮生长因子受体表达的影响.中国基层医药.2006,13(2):187-189.
[37]柳丽,张洪泉.丹参饮对胃溃疡大鼠部分粘膜防御因子的影响.中药新药与临床药理.2005,16(1):35-38.
[38]周慧芳,时昭红,张介眉.促愈颗粒对大鼠乙酸胃溃疡愈合质量的影响.湖北中医杂志.2006,28(3):13-14.
[39]谢斌,郑林,楚瑞阁.益胃汤对胃溃疡大鼠EGFR及bFGF的影响.江西中医学院学报.2008,20(5):66-67.
[40]曹名波,邹百仓,秦斌.荆花胃康胶丸对实验性胃溃疡大鼠粘膜愈合和EGF、EGFR表达的影响.新乡医学院学报.2006,23(5):478-480.
[41]蒋宁,郑洪新,才丽平等.中药消痈溃得康对乙酸胃溃疡模型大鼠TFF-2表达的影响.解剖科学进展.2010,16(4):343-346.
[42]潘华峰,赵霞,赵自明等.胃肠乐对乙酸慢性胃溃疡大鼠HSP70、HSP27表达及溃疡愈合质量的影响.北京中医药大学学报.2005,12(2):1-4.
[43]程丑夫,谭圣娥.疡必愈止痛片对大鼠实验性胃溃疡作用的研究及机制探讨.中国中医药科技.2001,8(2):108～109.
[1]Graham Dy,et al.Epidemiology of Campylobacter pylori infection:Ethnic considerations Scand .Gastroenterol.1988,23(142):9.
[2]张万岱,胡伏莲,萧树东等.中国自然人群幽门螺杆菌感染的流行病学调查.现代消化及介入诊疗.2010,15(5):265-270.
[3]Bafandeh Y,Esmaeeli H,Aharizad S.Helicobacter pylori infection rates in duodenal ulcer patients in apopulation with high prevalence of infection.Indian Gastroenterol.2005,24(3):130.
[4]GoodwinCS.Duodenal ulcer,Campylobacter Pylori and The“leakingroof”concept.Lancet.1988,2:1467-1469.
[5]叶任高,陆再英.内科学.第6版.北京.人民卫生出版社.2004.
[6]Levis S,Beardshall K,Haddad G,etal.Campy-Lobacterpylori and duodenal ulcers: Thegastrinlink .Lancet.1989,1:1167-1168.
[7]黄象谦.续述幽门螺杆菌感染与胃肠激素的联系.World Chin Jdigestor. 2005, 13(3): 282.
[8]Wyatt JI,Rathbone BJ,Sobala GM,etal.Gastric epithelium in the duodenal:its association with Helicopbacter pylori and inflammation.clin Pathal.1990,43: 981-986.
[9]王凌娟.幽门螺杆菌(HP)与胃溃疡.中国烧伤创疡杂志.2001,2(13):114.
[10]Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther,1996,10(Suppl 1):29-37.
[11]Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS , Prim-rose JN, Morgan AG. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut,1993,34:1339-1343.
[12]徐克强,张万岱,杨海涛.幽门螺杆菌与胃粘膜损伤:免疫病理学研究.国外医学内科学分册. 1997,24:208-210.
[13]Thijs JC van, Zwet AA, Thijs WJ,etal.Diagnostic tests for Helicobacter pylori:a prospective evaluation of their accuracy, without selecting a singletest as the gold standard. Am Jgastroenterol.1996, 91: 2125-2129.
[14]Jaup BH,Stenquist B,Brandberg A,et al.Helicobacter pyloriculture from a positive liquid-based urease test for routine clini-cal use a cost effective approach.Helicobacter.2000,5:22-23.
[15]Megraud F. Comparison of different tests for Campylobacterpylori. Scand Jgastroenterol.1988,142: 64-68.
[16]孔令丰.尿素[14C]呼气试验辐射影响评价.中国医疗前沿.2010,5(3):3-4.
[17]陈洁平,徐采朴.胶囊微量法14C-尿素呼气试验检测幽门螺杆菌感染的初步研究.中华消化杂志, 1995, 15(Suppl): 244-246.
[18]Vaira D,Malfertheiner P,Megraud F,Axon AT,Deltenre M,Hirschl AM,Gasbarrini G,OMorain C,GafCia JM,Qulna M,Tytgat GN.Diagnosis of Helieobacter Pylori in feetion with a new non invasive antigen based assay.HPSA.EuroPean study grouP.Lancet.1999,354:30-33。
[19]刘文忠,萧树东,王吉耀等.幽门螺杆菌粪便抗原试验的多中心研究.胃肠病学,2002,7(3):136-139.
[20]Gisbert JP,Trapero M,Pajares JM,et al.Evaluation of 3 different testsfor the detection of stool antigens to confirm Helicobacter pylori eradication after treatment.Apilot Study Gastroenterol Hepatol.2005,28(10):615-618
[21]王化冰,林三仁,周丽雅等.幽门螺杆菌粪便试验检测幽门螺杆菌的临床评价.中华消化杂志,2005,25(1):15-18.
[22]Solcia E,Villani L,Fiocca R,et al.Effects of eradicationof Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol, 1994, 201(suppl):28-34.
[23]Vigneri S, Termini R, Scialabba A, etal. Omeprazoletherapy modifies the gastric localization of Helicobacterpylori. Am J Gastroenterol, 1991, 86:1276.
[24]中华医学会消化病学分会幽门螺杆菌学组/幽门螺杆菌科研协作组.第三次全国幽门螺杆菌感染若干问题共识报告(2007.庐山).现代消化及介入诊疗.2008,13(1): 73-76.
[25]中华消化杂志编委会.消化性溃疡病诊断与治疗规范建议(2008.黄山).中华消化杂志,2008,28:447-450.
[26]Fock K M, Katelaris P, Sugano K, et al. Second Asia-PacificConsensus Guidelines for Helicobacter pylori infection.J Gastroenterol Hepatol.2009, 24: 1587-1600.
[27]Graham DY,Shiotani A.New concepts of resistance in the treatmentof H.pylori infection.Nat Clin Pract Gastroenterol Hepatol,2008,5:321-331.
[28]Tong J L,Ran Z H,Shen J,et al.Sequential therapy vs. standardtriple therapies for Helicobacter pylori infection: a meta-analysis. J Clin Pharm Ther,2009,34:41-53.
[29] Jafri N, Hornung C A,Howden C W. Meta-analysis: Sequentialtherapy appears superior to standard therapy for Helicobacter pyloriinfection in patients naive to treatment.Ann Intern Med. 2008,148: 1-10.
[1]中国中西医结合学会消化系统疾病专业委员会.消化性溃疡的中西医结合诊治方案.世界华人消化杂志.2004,12(11):2687-2689.
[2]国家技术监督局.中医临床诊疗术语证候部分.北京:中国标准出版社,1997.
[3]郑筱萸.中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002.
[4]苏新宁.数据仓库和数据挖掘.北京:清华大学出版社,2006.
[5]肖景东,周学文.创新“毒热”理论以痈论治消化性溃疡.中华中医药学刊.2008,26(6):1166-1168.
[6]周学文.胃溃疡活动期的中医证治.中华中医药学刊.2007,25(9):1775-1776.
[7]才丽平,蒋宁,曲怡等.“毒热证”胃溃疡大鼠模型的制备与评价.中华中医药杂志.2011,265(3):501-504.
[8]王树鹏,傅海燕,周学文.中医胃癌前状态性疾病“毒热”病因文献研究.辽宁中医杂志.2010,37(9):1664-1667.
[9]王垂杰,李玉峰,指导周学文.毒热与胃癌前状态.中医杂志.2011,52(1):79-80.
[10]周学文.“以痈论治”消化性溃疡的理论基础.中华中医药学会脾胃病分会第十八次学术交流会论文汇编,沈阳市,2006:265-266.
[11]周奇.以痈论治消化性溃疡的理论研究.辽宁中医杂志.2005,32(10):1081-1082.
[12]陈波华,刑洪君,张影等.浅述黄连等中药抑制幽门螺旋杆菌生长的试验研究.黑龙江医药.1996,9(2):115.
[13]凤良元.胃病与胃粘膜保护.上海:上海中医药大学出版社.2003.
[14]蔡水敏,任玉让,王黎等.最新中药药理与临床应用.北京:华夏出版社.1999.
[15]尤春来,韩兆丰,朱丹等.蒲公英对大鼠胃酸分泌的抑制作用及其对胃酸刺激药的影响.中药药理与临床.1994,10(2):23-26.
[16]白音人,莫日根,苦参碱对大鼠实验性胃粘膜损伤的保护作用.中草药.1996,27(12):729-731.
[17]罗光宇,欧芳春.“十八反”药物相互作用的研究:川乌反白及的初步试验.上海中医药杂志.1989,(12):1-3.
[18]王再谟,傅荣周,唐章全.现代中药临床应用.北京:人民卫生出版社,2005.
[19]王本样.现代中药药理学.天津.天津科学技术出版社.1997.
[20]黄春林,朱晓新.中药药理与临床手册.北京.人民卫生出版社,2006.
[21]周学文,李刚,姜树民等.消化性溃疡中医辨治的临床研究.中国中西医结合脾胃杂志.1994,2(1):4-6.
[22]李玉锋,王垂杰,周学文等.消痈溃得康颗粒治疗活动期胃溃疡270例.中医研究2011,24(1):35-37.
[23]白光,王垂杰,姜巍等.消痈溃得康颗粒对胃溃疡活动期患者血清三叶因子及表皮生长因子的影响.中国中西医结合消化杂志.2011,19(1):1-3.
[24]王垂杰,王辉,李岩等.消痈溃得康颗粒对胃溃疡活动期(毒热证)胃粘膜组织中三叶因子、表皮生长因子表达的影响.中华中医药学刊.2011,29(3):456-459.
[25]白光,王垂杰,姜巍等.消痈溃得康颗粒对胃溃疡活动期患者血清前列腺素及肿瘤坏死因子的影响.中华中医药学刊.2010,28(11):2270-2272.
[26]肖景东.清热解毒、消痈生肌法对乙酸致胃溃疡大鼠溃疡愈合影响的实验研究.博士学位论文.沈阳.辽宁中医药大学.2008.
[27]蒋宁,郑洪新,才丽平等.中药消痈溃得康对乙酸胃溃疡模型大鼠TFF-2表达的影响.解剖科学进展. 2010,16(4):343-349.
[28]白光,周学文.消痈溃得康对乙酸型胃溃疡大鼠血清NO NOS含量影响的实验研究.辽宁中医杂志.2010,37(11):2132-2133.
[29]周学文.脾胃气机升降理论与临床运用举隅.中国中西医结合脾胃杂志.1994,5(3):129-130.
[30]严华.根除幽门螺旋杆菌与消化性溃疡复发的关系.临床医学,2003,23(8):2-3.
[31]邱世犹,陈文力.幽门螺旋杆菌根除方案的临床研究.中国医院用药评价与分析.2000,2(1):50-51.
[32]洪流,吴开春.幽门螺杆菌感染的黏膜损伤免疫机制和免疫治疗的研究进展.胃肠病学.2007,12(9):563-566.
[33]夏勇,吴惠玲,傅剑云等.建立胃损伤模型的方法及选择.实用预防医学.2005,12(3):659-661.
[1]杨子敬.消化性溃疡的研究进展.内科.2009,(6):925-927.
[2]林庚金.消化病新概念.上海:上海医科大学出版社,1997.
[3]Cochrane协作网. WWW.Cochrane-handbook.org.
[4]Gordon H Guyatt, Andrew D Oxman, Regina Kunz等.GRADE:什么是“证据质量”?为什么它对临床医生重要?中国循证医学杂志.2009,9(2):133-137.
[5]杨克虎,循证医学.北京:人民卫生出版社,2006.
[6]倪依东,刘友章,张惠臣.胃乃安胶囊治疗胃脘痛的临床研究.中药新药与临床药理. 2002,13(6):353-355.
[7]张瑞明,王蕾,陈光远等.海桂愈疡胶囊治疗十二指肠球部溃疡的随机双盲对照试验.四川大学学报(医学版). 2005,36(2):233-236.
[8]李俊,梅广源,谭荣益等.金牛腹痛片治疗活动期消化性溃疡的疗效观察.中国中西医结合脾胃杂志. 2000,8( 5):270-272.
[9]李家邦,李益强,陈国林等.健胃愈疡片治疗消化性溃疡的临床研究.中西医结合杂志. 1991,l1(3):141-143.
[10]李诗国,姚开建,刘景山等.自制胃炎灵治疗胃溃疡的临床效果.实用医药杂志. 200,2O(5):376.
[11]林炳辉,方素钦,叶盈等.荆花胃康与雷尼替丁治疗十二指肠溃疡的对照研究.中国新药杂志.2001,10(3):224-226.
[12]梁小庆,丁洪明,李爱国等.健胃愈疡片治疗消化性溃疡314例临床疗效与安全性.中国临床药理学与治疗学.2002,12(7):835-837.
[13]王新春,韩大正,胡秀赞等.胃乐胶囊治疗187例消化性溃疡的疗效观察.新医学. 2003, 34(9):554-555.
[14]苏健,陈方锐,刘天舒.超微疏肝消溃汤治疗肝郁脾虚型消化性溃疡63例临床观察.中医药导报.2010,16(5):37-39.
[15]董明国,何世东,叶小汉.康尔胃治疗消化性溃疡临床及实验研究.现代消化病及内镜杂志.1998,3(4):54-56.
[16]郑昱.蒲公英胶囊抗消化性溃疡复发及其对外周血T淋巴细胞亚群的调节作用.中国中医药信息杂志. 2003,lO( 5):14-15.
[17]黄国栋,黄媛华.健胃愈疡颗粒干预下胃溃疡黏膜PS_2和PAF的表达及其抗PU复发的机理探讨.中药材.2007,30(12):1625-1629.
[18]黄恒青,王启国,王文荣等.胃得安片治疗十二指肠溃疡临床研究.福建中医药2003,34(2):7-10.
[19]吴泰相,李幼平,卞兆祥等.中医药临床随机对照试验报告规范(征求意见稿).中国循证医学杂志.2007,7(8):601-605.
[2]刘波,陆明,刘凡.野甘草乙醇提取物治疗大鼠胃溃疡作用的研究.现代中西医结合杂志.2007,16( 19):2654.
[3]唐绪刚,黄文权.五灵脂药理及临床应用概述.中国中医急症.2008,17(1):101-102.
[4]杨芳.沙棘的研究进展.第一军医大学分校学报.2004,27(1):79-81.
[5]陈少夫,贺丽,周卓等.党参对兔胃十二指肠粘膜中胃泌素、生长抑素的影响.中国医科大学学报.2002,31(3):164-165.
[6]Jackson CA. Rapid renal potassium adaptation in rats.Am J Physiol. 1992 Dec;263(6 Pt 2): 1098-104.
[7]龚静.大黄研究新进展.上海医药.2007,28(11):509-510.
[8]刘小英,温永顺,李裕福等.鱼腥草煎液对幽门螺杆菌的抑菌作用.第四军医大学学报.2006,27(8):676.
[9]Jiang XL, Cui HF. Different therapy for different types of ulcerative colitis in China.World J Gastroenterol. 2004 May 15;10(10):1513-20.
[10] Bae EA, Han MJ, Baek NI, Kim DH.In vitro anti-Helicobacter pylori activity of panaxytriol isolated from ginseng. Arch Pharm Res. 2001,24(4):297-9.
[11]钱士辉,王佾先,亢寿海等.陈皮提取物体内抗肿瘤作用的研究.中药材.2002, 26 (10) : 744-745.
[12]李庆耀,梁生林.陈皮的药用研究进展.中成药.2008,30(2):246-247.
[13]李廷荃,王希星,马贵同.黄芪对大鼠胃溃疡愈合过程中表皮生长因子及其受体表达的影响.山西中医.2007,23(2):61-63.
[14]孙仁山,陈晓红,程天民等.白芨对大鼠创面愈合几个要素的影响.中国临床康复.2003,7(29):3927-3929
[15]黄龑,孙清华,胡旭姣.白芨多糖对动物实验性胃溃疡的影响.现代中西医结合杂志.2009,18(6):612-613.
[16]丁志山,蒋福升,高承贤等.姜黄素对动物实验性胃溃疡的影响研究.中华中医药学刊,2008,26(10): 2225-2226.
[17]林海鸣,许琼明,孙晓飞.中草药.2008,39(12):1861-1863.
[18]卫自,沈业寿,史新强.天麻糖蛋白对小鼠实验性胃溃疡的保护作用.中药药理与临床.2007,23(6):34-35.
[19]梅武轩,曾常春.乳香提取物对大鼠乙酸胃溃疡愈合质量的影响.中国中西医结合消化杂志.2004,12(1):34-36.
[20] Tominaga K, Higuchi K, Iketani T et al .Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients. Inflammopharmacology. 2007,15(2):84-9.
[21]黄国栋,黄媛华,黄道富等.沙棘原花青素抗胃溃疡作用机制的研究.中成药.2008,30(5):632-635.
[22]付辛芳,刘晓红.丹参的药理作用与临床应用研究进展.中国药业.2006,15(1):76-77.
[23]李廷荃,马贵同,赵晋明.丹参对大鼠胃溃疡愈合过程中碱性成纤维细胞生长因子及其受体表达的影响.上海中医药杂志.2005,39(12):51-53.
[24]周奇.复方芪连煎剂治疗胃溃疡的实验研究.辽宁中医志.2005,32(12):1314-1315.
[25]张国民,刘慧萍,莫新民等.疏肝和胃丸对幽门结扎胃溃疡大鼠胃黏膜G细胞的调节作用.中华中医药学刊.2007,25(10):2102-2103。
[26]彭连生,胡锡元,曹淑亚等.健胃口服液抗消化性溃疡的药理研究.中国中西医结合消化杂志.2001,9(3):150-152.
[27]郝慧泉,田玉芝,曹径琳等.溃疡宁胶囊对大鼠幽门螺杆菌感染性胃溃疡实验研究.河北医药.2003,2(10):725-727.
[28]李春梅,梁代英,刘晋生等.养阴颗粒治疗幽门螺杆菌感染实验性胃溃疡的实验研究.北京中医杂志.2002,21(5):309-340.
[29]张俊杰,周庚生,顾伟忠,等.芩连合剂对幽门螺杆菌感染性胃溃疡大鼠氧自由基参数的影响.中国中医药科技.2O06,13(3):157-158
[30]李冀,毕塘辉,孙宇峰.四逆散抗实验性胃溃疡的药效学及作用机理研究.中华中医药学刊. 2007,25 (7):1317-1319.
[31]汪艳娟,王行宽,胡国恒.止血愈疡颗粒对幽门结扎型胃溃疡大鼠氧自由基参数的影响.中国中西医结合消化杂志.2002,10(4):206-208.
[32]白光,周学文.消痈溃得康对乙酸型胃溃疡大鼠血清NO NOS含量影响的实验研究.辽宁中医杂志.2010,37(1):2132-2133.
[33]张学智,李超波,梁文郁.复方田七胃痛胶囊对胃溃疡大鼠胃黏膜一氧化氮及内皮素的影响.中国中西医结合消化杂志.2008,16(5):281-283.
[34]李佃贵,王静,李瑞东.化浊降逆法对胃溃疡大鼠胃组织形态及血清NO血浆ET PAF含量的影响.河北职工医学院学报.2005,22(1):1-3.
[35]王滨,赵红晔,周丽等.溃疡平对胃溃疡大鼠胃黏膜组织中EGF和EGFRmRNA表达的影响.北京中医药大学学报.2008,31(11):759-762.
[36]谭永港,刘志承,张永锋等.健胃汤对大鼠胃溃疡愈合质量及表皮生长因子受体表达的影响.中国基层医药.2006,13(2):187-189.
[37]柳丽,张洪泉.丹参饮对胃溃疡大鼠部分粘膜防御因子的影响.中药新药与临床药理.2005,16(1):35-38.
[38]周慧芳,时昭红,张介眉.促愈颗粒对大鼠乙酸胃溃疡愈合质量的影响.湖北中医杂志.2006,28(3):13-14.
[39]谢斌,郑林,楚瑞阁.益胃汤对胃溃疡大鼠EGFR及bFGF的影响.江西中医学院学报.2008,20(5):66-67.
[40]曹名波,邹百仓,秦斌.荆花胃康胶丸对实验性胃溃疡大鼠粘膜愈合和EGF、EGFR表达的影响.新乡医学院学报.2006,23(5):478-480.
[41]蒋宁,郑洪新,才丽平等.中药消痈溃得康对乙酸胃溃疡模型大鼠TFF-2表达的影响.解剖科学进展.2010,16(4):343-346.
[42]潘华峰,赵霞,赵自明等.胃肠乐对乙酸慢性胃溃疡大鼠HSP70、HSP27表达及溃疡愈合质量的影响.北京中医药大学学报.2005,12(2):1-4.
[43]程丑夫,谭圣娥.疡必愈止痛片对大鼠实验性胃溃疡作用的研究及机制探讨.中国中医药科技.2001,8(2):108～109.
[1]Graham Dy,et al.Epidemiology of Campylobacter pylori infection:Ethnic considerations Scand .Gastroenterol.1988,23(142):9.
[2]张万岱,胡伏莲,萧树东等.中国自然人群幽门螺杆菌感染的流行病学调查.现代消化及介入诊疗.2010,15(5):265-270.
[3]Bafandeh Y,Esmaeeli H,Aharizad S.Helicobacter pylori infection rates in duodenal ulcer patients in apopulation with high prevalence of infection.Indian Gastroenterol.2005,24(3):130.
[4]GoodwinCS.Duodenal ulcer,Campylobacter Pylori and The“leakingroof”concept.Lancet.1988,2:1467-1469.
[5]叶任高,陆再英.内科学.第6版.北京.人民卫生出版社.2004.
[6]Levis S,Beardshall K,Haddad G,etal.Campy-Lobacterpylori and duodenal ulcers: Thegastrinlink .Lancet.1989,1:1167-1168.
[7]黄象谦.续述幽门螺杆菌感染与胃肠激素的联系.World Chin Jdigestor. 2005, 13(3): 282.
[8]Wyatt JI,Rathbone BJ,Sobala GM,etal.Gastric epithelium in the duodenal:its association with Helicopbacter pylori and inflammation.clin Pathal.1990,43: 981-986.
[9]王凌娟.幽门螺杆菌(HP)与胃溃疡.中国烧伤创疡杂志.2001,2(13):114.
[10]Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther,1996,10(Suppl 1):29-37.
[11]Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS , Prim-rose JN, Morgan AG. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut,1993,34:1339-1343.
[12]徐克强,张万岱,杨海涛.幽门螺杆菌与胃粘膜损伤:免疫病理学研究.国外医学内科学分册. 1997,24:208-210.
[13]Thijs JC van, Zwet AA, Thijs WJ,etal.Diagnostic tests for Helicobacter pylori:a prospective evaluation of their accuracy, without selecting a singletest as the gold standard. Am Jgastroenterol.1996, 91: 2125-2129.
[14]Jaup BH,Stenquist B,Brandberg A,et al.Helicobacter pyloriculture from a positive liquid-based urease test for routine clini-cal use a cost effective approach.Helicobacter.2000,5:22-23.
[15]Megraud F. Comparison of different tests for Campylobacterpylori. Scand Jgastroenterol.1988,142: 64-68.
[16]孔令丰.尿素[14C]呼气试验辐射影响评价.中国医疗前沿.2010,5(3):3-4.
[17]陈洁平,徐采朴.胶囊微量法14C-尿素呼气试验检测幽门螺杆菌感染的初步研究.中华消化杂志, 1995, 15(Suppl): 244-246.
[18]Vaira D,Malfertheiner P,Megraud F,Axon AT,Deltenre M,Hirschl AM,Gasbarrini G,OMorain C,GafCia JM,Qulna M,Tytgat GN.Diagnosis of Helieobacter Pylori in feetion with a new non invasive antigen based assay.HPSA.EuroPean study grouP.Lancet.1999,354:30-33。
[19]刘文忠,萧树东,王吉耀等.幽门螺杆菌粪便抗原试验的多中心研究.胃肠病学,2002,7(3):136-139.
[20]Gisbert JP,Trapero M,Pajares JM,et al.Evaluation of 3 different testsfor the detection of stool antigens to confirm Helicobacter pylori eradication after treatment.Apilot Study Gastroenterol Hepatol.2005,28(10):615-618
[21]王化冰,林三仁,周丽雅等.幽门螺杆菌粪便试验检测幽门螺杆菌的临床评价.中华消化杂志,2005,25(1):15-18.
[22]Solcia E,Villani L,Fiocca R,et al.Effects of eradicationof Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol, 1994, 201(suppl):28-34.
[23]Vigneri S, Termini R, Scialabba A, etal. Omeprazoletherapy modifies the gastric localization of Helicobacterpylori. Am J Gastroenterol, 1991, 86:1276.
[24]中华医学会消化病学分会幽门螺杆菌学组/幽门螺杆菌科研协作组.第三次全国幽门螺杆菌感染若干问题共识报告(2007.庐山).现代消化及介入诊疗.2008,13(1): 73-76.
[25]中华消化杂志编委会.消化性溃疡病诊断与治疗规范建议(2008.黄山).中华消化杂志,2008,28:447-450.
[26]Fock K M, Katelaris P, Sugano K, et al. Second Asia-PacificConsensus Guidelines for Helicobacter pylori infection.J Gastroenterol Hepatol.2009, 24: 1587-1600.
[27]Graham DY,Shiotani A.New concepts of resistance in the treatmentof H.pylori infection.Nat Clin Pract Gastroenterol Hepatol,2008,5:321-331.
[28]Tong J L,Ran Z H,Shen J,et al.Sequential therapy vs. standardtriple therapies for Helicobacter pylori infection: a meta-analysis. J Clin Pharm Ther,2009,34:41-53.
[29] Jafri N, Hornung C A,Howden C W. Meta-analysis: Sequentialtherapy appears superior to standard therapy for Helicobacter pyloriinfection in patients naive to treatment.Ann Intern Med. 2008,148: 1-10.
[1]中国中西医结合学会消化系统疾病专业委员会.消化性溃疡的中西医结合诊治方案.世界华人消化杂志.2004,12(11):2687-2689.
[2]国家技术监督局.中医临床诊疗术语证候部分.北京:中国标准出版社,1997.
[3]郑筱萸.中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002.
[4]苏新宁.数据仓库和数据挖掘.北京:清华大学出版社,2006.
[5]肖景东,周学文.创新“毒热”理论以痈论治消化性溃疡.中华中医药学刊.2008,26(6):1166-1168.
[6]周学文.胃溃疡活动期的中医证治.中华中医药学刊.2007,25(9):1775-1776.
[7]才丽平,蒋宁,曲怡等.“毒热证”胃溃疡大鼠模型的制备与评价.中华中医药杂志.2011,265(3):501-504.
[8]王树鹏,傅海燕,周学文.中医胃癌前状态性疾病“毒热”病因文献研究.辽宁中医杂志.2010,37(9):1664-1667.
[9]王垂杰,李玉峰,指导周学文.毒热与胃癌前状态.中医杂志.2011,52(1):79-80.
[10]周学文.“以痈论治”消化性溃疡的理论基础.中华中医药学会脾胃病分会第十八次学术交流会论文汇编,沈阳市,2006:265-266.
[11]周奇.以痈论治消化性溃疡的理论研究.辽宁中医杂志.2005,32(10):1081-1082.
[12]陈波华,刑洪君,张影等.浅述黄连等中药抑制幽门螺旋杆菌生长的试验研究.黑龙江医药.1996,9(2):115.
[13]凤良元.胃病与胃粘膜保护.上海:上海中医药大学出版社.2003.
[14]蔡水敏,任玉让,王黎等.最新中药药理与临床应用.北京:华夏出版社.1999.
[15]尤春来,韩兆丰,朱丹等.蒲公英对大鼠胃酸分泌的抑制作用及其对胃酸刺激药的影响.中药药理与临床.1994,10(2):23-26.
[16]白音人,莫日根,苦参碱对大鼠实验性胃粘膜损伤的保护作用.中草药.1996,27(12):729-731.
[17]罗光宇,欧芳春.“十八反”药物相互作用的研究:川乌反白及的初步试验.上海中医药杂志.1989,(12):1-3.
[18]王再谟,傅荣周,唐章全.现代中药临床应用.北京:人民卫生出版社,2005.
[19]王本样.现代中药药理学.天津.天津科学技术出版社.1997.
[20]黄春林,朱晓新.中药药理与临床手册.北京.人民卫生出版社,2006.
[21]周学文,李刚,姜树民等.消化性溃疡中医辨治的临床研究.中国中西医结合脾胃杂志.1994,2(1):4-6.
[22]李玉锋,王垂杰,周学文等.消痈溃得康颗粒治疗活动期胃溃疡270例.中医研究2011,24(1):35-37.
[23]白光,王垂杰,姜巍等.消痈溃得康颗粒对胃溃疡活动期患者血清三叶因子及表皮生长因子的影响.中国中西医结合消化杂志.2011,19(1):1-3.
[24]王垂杰,王辉,李岩等.消痈溃得康颗粒对胃溃疡活动期(毒热证)胃粘膜组织中三叶因子、表皮生长因子表达的影响.中华中医药学刊.2011,29(3):456-459.
[25]白光,王垂杰,姜巍等.消痈溃得康颗粒对胃溃疡活动期患者血清前列腺素及肿瘤坏死因子的影响.中华中医药学刊.2010,28(11):2270-2272.
[26]肖景东.清热解毒、消痈生肌法对乙酸致胃溃疡大鼠溃疡愈合影响的实验研究.博士学位论文.沈阳.辽宁中医药大学.2008.
[27]蒋宁,郑洪新,才丽平等.中药消痈溃得康对乙酸胃溃疡模型大鼠TFF-2表达的影响.解剖科学进展. 2010,16(4):343-349.
[28]白光,周学文.消痈溃得康对乙酸型胃溃疡大鼠血清NO NOS含量影响的实验研究.辽宁中医杂志.2010,37(11):2132-2133.
[29]周学文.脾胃气机升降理论与临床运用举隅.中国中西医结合脾胃杂志.1994,5(3):129-130.
[30]严华.根除幽门螺旋杆菌与消化性溃疡复发的关系.临床医学,2003,23(8):2-3.
[31]邱世犹,陈文力.幽门螺旋杆菌根除方案的临床研究.中国医院用药评价与分析.2000,2(1):50-51.
[32]洪流,吴开春.幽门螺杆菌感染的黏膜损伤免疫机制和免疫治疗的研究进展.胃肠病学.2007,12(9):563-566.
[33]夏勇,吴惠玲,傅剑云等.建立胃损伤模型的方法及选择.实用预防医学.2005,12(3):659-661.
[1]杨子敬.消化性溃疡的研究进展.内科.2009,(6):925-927.
[2]林庚金.消化病新概念.上海:上海医科大学出版社,1997.
[3]Cochrane协作网. WWW.Cochrane-handbook.org.
[4]Gordon H Guyatt, Andrew D Oxman, Regina Kunz等.GRADE:什么是“证据质量”?为什么它对临床医生重要?中国循证医学杂志.2009,9(2):133-137.
[5]杨克虎,循证医学.北京:人民卫生出版社,2006.
[6]倪依东,刘友章,张惠臣.胃乃安胶囊治疗胃脘痛的临床研究.中药新药与临床药理. 2002,13(6):353-355.
[7]张瑞明,王蕾,陈光远等.海桂愈疡胶囊治疗十二指肠球部溃疡的随机双盲对照试验.四川大学学报(医学版). 2005,36(2):233-236.
[8]李俊,梅广源,谭荣益等.金牛腹痛片治疗活动期消化性溃疡的疗效观察.中国中西医结合脾胃杂志. 2000,8( 5):270-272.
[9]李家邦,李益强,陈国林等.健胃愈疡片治疗消化性溃疡的临床研究.中西医结合杂志. 1991,l1(3):141-143.
[10]李诗国,姚开建,刘景山等.自制胃炎灵治疗胃溃疡的临床效果.实用医药杂志. 200,2O(5):376.
[11]林炳辉,方素钦,叶盈等.荆花胃康与雷尼替丁治疗十二指肠溃疡的对照研究.中国新药杂志.2001,10(3):224-226.
[12]梁小庆,丁洪明,李爱国等.健胃愈疡片治疗消化性溃疡314例临床疗效与安全性.中国临床药理学与治疗学.2002,12(7):835-837.
[13]王新春,韩大正,胡秀赞等.胃乐胶囊治疗187例消化性溃疡的疗效观察.新医学. 2003, 34(9):554-555.
[14]苏健,陈方锐,刘天舒.超微疏肝消溃汤治疗肝郁脾虚型消化性溃疡63例临床观察.中医药导报.2010,16(5):37-39.
[15]董明国,何世东,叶小汉.康尔胃治疗消化性溃疡临床及实验研究.现代消化病及内镜杂志.1998,3(4):54-56.
[16]郑昱.蒲公英胶囊抗消化性溃疡复发及其对外周血T淋巴细胞亚群的调节作用.中国中医药信息杂志. 2003,lO( 5):14-15.
[17]黄国栋,黄媛华.健胃愈疡颗粒干预下胃溃疡黏膜PS_2和PAF的表达及其抗PU复发的机理探讨.中药材.2007,30(12):1625-1629.
[18]黄恒青,王启国,王文荣等.胃得安片治疗十二指肠溃疡临床研究.福建中医药2003,34(2):7-10.
[19]吴泰相,李幼平,卞兆祥等.中医药临床随机对照试验报告规范(征求意见稿).中国循证医学杂志.2007,7(8):601-605.